Context Therapeutics Inc. (CNTX) Quarterly Income Statement

120+ quarters historyFree accessUpdated daily

Context Therapeutics Inc. (CNTX) quarterly income statement — complete revenue, gross profit & net income history

Quarterly statement

CNTX Income Statement

Context Therapeutics Inc. (CNTX) annual income statement — 7-year revenue, gross profit & net income history

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24	Q4'23	Q3'23	Q2'23	Q1'23	Q4'22	Q3'22	Q2'22	Q1'22	Q4'21	Q3'21

Sales/Revenue	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Revenue Growth %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost of Goods Sold	0	0	0	4.07K	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
COGS % of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	0	0	0	-4.07K	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Gross Margin %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit Growth %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Expenses	14.97M	9.34M	13.8M	10.61M	9.76M	5.53M	4.31M	18.7M	3.09M	3.82M	6.93M	6.18M	5.29M	6.67M	3.88M	4.05M	4.01M	3.44M	3.09M	1.57M
OpEx % of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Selling, General & Admin	2.44M	2.33M	1.96M	1.89M	1.93M	2.07M	1.79M	1.88M	1.7M	1.85M	1.63M	1.7M	1.83M	2.13M	1.74M	1.97M	1.99M	2.09M	1.8M	828.46K
SG&A % of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Research & Development	12.53M	7.02M	11.84M	8.72M	7.83M	3.46M	2.52M	16.83M	1.38M	1.97M	5.3M	4.49M	3.46M	4.53M	2.14M	2.08M	1.52M	1.35M	1.29M	739.6K
R&D % of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other Operating Expenses	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	500K	0	0	0
Operating Income	-14.97M	-9.34M	-13.8M	-10.61M	-9.76M	-5.53M	-4.31M	-18.7M	-3.09M	-3.82M	-6.93M	-6.18M	-5.29M	-6.67M	-3.88M	-4.05M	-4.01M	-3.44M	-3.09M	-1.57M
Operating Margin %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income Growth %	-53.38%	-68.99%	-220.26%	43.26%	-215.95%	-44.61%	37.83%	-202.59%	41.64%	42.65%	-78.58%	-52.68%	-32.05%	-93.63%	-25.56%	-158.16%	20.25%	-309.72%	-301.78%	-
EBITDA	-14.56M	-9.31M	-13.8M	-10.61M	-9.75M	-5.53M	-4.31M	-18.7M	-3.09M	-3.82M	-6.93M	-6.18M	-5.29M	-6.66M	-3.88M	-4.04M	-4M	-3.44M	-3.09M	-1.57M
EBITDA Margin %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EBITDA Growth %	-49.25%	-68.46%	-220.39%	43.28%	-216.08%	-44.6%	37.85%	-202.69%	41.65%	42.66%	-78.66%	-52.72%	-32.07%	-93.54%	-25.45%	-157.96%	-106.68%	-309.72%	-347.94%	-
D&A (Non-Cash Add-back)	0	36.1K	4.07K	4.07K	4.07K	4.05K	2.93K	2.81K	2.57K	2.57K	2.57K	3.09K	3.19K	3.19K	3.19K	3.19K	2.88K	0	0	0
EBIT	-14.56M	-8.68M	-13.03M	-9.69M	-8.83M	-4.58M	-3.34M	-17.46M	-2.25M	-3.67M	-6.93M	-6.18M	-5.29M	-6.67M	-3.88M	-4.05M	-3.51M	-3.44M	-3.09M	-1.57M
Net Interest Income	418.66K	520.14K	682.48K	833.77K	903.77K	958.52K	964.04K	1.24M	840.15K	152.35K	224.72K	290.44K	293.27K	355.54K	327.86K	192.25K	21.3K	5.86K	315	-1.26K
Interest Income	418.66K	520.14K	682.48K	833.77K	903.77K	958.52K	964.04K	1.24M	840.15K	152.35K	224.72K	290.44K	293.27K	355.54K	327.86K	192.25K	21.3K	5.86K	315	0
Interest Expense	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.26K
Other Income/Expense	409.06K	663.23K	779.04K	917.24K	930.85K	951.88K	967.51K	1.24M	834.04K	155.7K	163.32K	305.81K	281.05K	358.23K	325.56K	193.78K	21.3K	4.63K	39	125.27K
Pretax Income	-14.56M	-8.68M	-13.03M	-9.69M	-8.83M	-4.58M	-3.34M	-17.46M	-2.25M	-3.67M	-6.77M	-5.87M	-5.01M	-6.31M	-3.56M	-3.85M	-3.99M	-3.44M	-3.09M	-1.44M
Pretax Margin %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Income Tax	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Effective Tax Rate %	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%
Net Income	-14.56M	-8.68M	-13.03M	-9.69M	-8.83M	-4.58M	-3.34M	-17.46M	-2.25M	-3.67M	-6.77M	-5.87M	-5.01M	-6.31M	-3.56M	-3.85M	-3.99M	-3.44M	-3.09M	-1.44M
Net Margin %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income Growth %	-64.92%	-89.65%	-289.65%	44.48%	-291.55%	-24.8%	50.62%	-197.21%	55.01%	41.86%	-90.34%	-52.42%	-25.71%	-83.47%	-15.04%	-167.14%	20.75%	-285.44%	-293.99%	-
Net Income (Continuing)	-14.56M	-8.68M	-13.03M	-9.69M	-8.83M	-4.58M	-3.34M	-17.46M	-2.25M	-3.67M	-6.77M	-5.87M	-5.01M	-6.31M	-3.56M	-3.85M	-3.99M	-3.44M	-3.09M	-1.44M
Discontinued Operations	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
EPS (Diluted)	-0.15	-0.09	-0.14	-0.10	-0.09	-0.05	-0.06	-0.22	-0.04	-0.23	-0.42	-0.37	-0.31	-0.40	-0.22	-0.24	-0.25	-0.22	-0.30	-0.21
EPS Growth %	-61.81%	-82.4%	-144.76%	54.55%	-126.1%	78.26%	86.38%	40.54%	86.77%	42.5%	-88.52%	-54.17%	-24%	-81.82%	25.74%	-14.29%	65.75%	-151.72%	-290.12%	-
EPS (Basic)	-0.15	-0.09	-0.14	-0.10	-0.09	-0.05	-0.06	-0.22	-0.04	-0.23	-0.42	-0.37	-0.31	-0.40	-0.22	-0.24	-0.25	-0.22	-0.30	-0.21
Diluted Shares Outstanding	95.18M	95.18M	91.88M	95.19M	95.19M	95.19M	58.42M	80.48M	54.96M	15.97M	15.97M	15.97M	15.97M	15.97M	15.97M	15.97M	15.97M	15.97M	10.21M	361.07K
Basic Shares Outstanding	95.18M	95.18M	91.88M	95.19M	95.19M	95.19M	58.42M	80.48M	54.96M	15.97M	15.97M	15.97M	15.97M	15.97M	15.97M	15.97M	15.97M	15.97M	10.21M	361K
Dividend Payout Ratio	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-